Evaluation of Long-Acting Lenacapavir for the Treatment of HIV-1 in Treatment-experienced Adolescents and Children

Clinical trial NCT06749054 · RECRUITING

Trial details

NCT number: NCT06749054
Sponsor: Gilead Sciences
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

HIV-1-infection

Start date: 2025-03-26
Primary completion: 2027-03-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.